Last 12 months
Inside the activity.
0 purchase rows · 64 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 24 |
| Dec 2025 | 0 | 6 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 12 |
| Mar 2026 | 0 | 13 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 23, 2024 Filed Mar 15, 2024 00:36 UTC Amendment |
Stanton Marshall S.SVP, Clinical & MD Affair
|
GrantCommon Stock | 10,644 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000154 · wk-form4a_1710462983.xml · nonDerivative · entry 3 Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,157 F4 · shares: Represents performance stock units granted on Feb. 22, 2023. Fifty percent (50%) were issued on Feb. 23, 2024. The remaining shares earned in connection with the Feb. 2023 grant will be eligible to vest and be issued as follows: 25% on 02/22/2025; and 25% on 02/22/2026, assuming employment on the relevant vesting date. F3 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4. Read SEC document |
| February 23, 2024 Filed Mar 15, 2024 00:36 UTC Amendment |
Stanton Marshall S.SVP, Clinical & MD Affair
|
GrantCommon Stock | 5,386 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000154 · wk-form4a_1710462983.xml · nonDerivative · entry 1 Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,089 F1 · shares: Represents performance stock units granted on Feb. 22, 2023. One hundred percent (100%) were issued on Feb. 23, 2024. Read SEC document |
| February 23, 2024 Filed Mar 15, 2024 00:33 UTC Amendment |
Maney Rochelle L.VP, Quality
|
GrantCommon Stock | 6,418 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000152 · wk-form4a_1710462815.xml · nonDerivative · entry 3 Maney Rochelle L. · CIK 0001850597 · VP, Quality 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,632 F4 · shares: Represents performance stock units granted on Feb. 22, 2023. Fifty percent (50%) were issued on Feb. 23, 2024. The remaining shares earned in connection with the Feb. 2023 grant will be eligible to vest and be issued as follows: 25% on 02/22/2025; and 25% on 02/22/2026, assuming employment on the relevant vesting date. F3 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4. Read SEC document |
| February 23, 2024 Filed Mar 15, 2024 00:33 UTC Amendment |
Maney Rochelle L.VP, Quality
|
GrantCommon Stock | 3,366 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000152 · wk-form4a_1710462815.xml · nonDerivative · entry 1 Maney Rochelle L. · CIK 0001850597 · VP, Quality 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,382 F1 · shares: Represents performance stock units granted on Feb. 22, 2023. One hundred percent (100%) were issued on Feb. 23, 2024. Read SEC document |
| February 23, 2024 Filed Mar 15, 2024 00:31 UTC Amendment |
Holloway Jean FSVP, General Counsel
|
GrantCommon Stock | 12,836 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000150 · wk-form4a_1710462676.xml · nonDerivative · entry 3 Holloway Jean F · CIK 0001540065 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 168,395 F4 · shares: Represents performance stock units granted on Feb. 22, 2023. Fifty percent (50%) were issued on Feb. 23, 2024. The remaining shares earned in connection with the Feb. 2023 grant will be eligible to vest and be issued as follows: 25% on 02/22/2025; and 25% on 02/22/2026, assuming employment on the relevant vesting date. F3 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4. Read SEC document |
| February 23, 2024 Filed Mar 15, 2024 00:31 UTC Amendment |
Holloway Jean FSVP, General Counsel
|
GrantCommon Stock | 5,386 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000150 · wk-form4a_1710462676.xml · nonDerivative · entry 1 Holloway Jean F · CIK 0001540065 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,854 F1 · shares: Represents performance stock units granted on Feb. 22, 2023. One hundred percent (100%) were issued on Feb. 23, 2024. Read SEC document |
| February 23, 2024 Filed Mar 15, 2024 00:29 UTC Amendment |
GREEN ANDREW MVP Regulatory
|
GrantCommon Stock | 6,914 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000148 · wk-form4a_1710462542.xml · nonDerivative · entry 3 GREEN ANDREW M · CIK 0001191000 · VP Regulatory 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,779 F4 · shares: Represents performance stock units granted on Feb. 22, 2023. Fifty percent (50%) were issued on Feb. 23, 2024. The remaining shares earned in connection with the Feb. 2023 grant will be eligible to vest and be issued as follows: 25% on 02/22/2025; and 25% on 02/22/2026, assuming employment on the relevant vesting date. F3 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4. Read SEC document |
| February 23, 2024 Filed Mar 15, 2024 00:29 UTC Amendment |
GREEN ANDREW MVP Regulatory
|
GrantCommon Stock | 3,366 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000148 · wk-form4a_1710462542.xml · nonDerivative · entry 1 GREEN ANDREW M · CIK 0001191000 · VP Regulatory 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,033 F1 · shares: Represents performance stock units granted on Feb. 22, 2023. One hundred percent (100%) were issued on Feb. 23, 2024. Read SEC document |
| February 23, 2024 Filed Mar 15, 2024 00:27 UTC Amendment |
Davis John EChief Commercial Officer
|
GrantCommon Stock | 12,736 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000146 · wk-form4a_1710462424.xml · nonDerivative · entry 3 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,447 F4 · shares: Represents performance stock units granted on Feb. 22, 2023. Fifty percent (50%) were issued on Feb. 23, 2024. The remaining shares earned in connection with the Feb. 2023 grant will be eligible to vest and be issued as follows: 25% on 02/22/2025; and 25% on 02/22/2026, assuming employment on the relevant vesting date. F3 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4. Read SEC document |
| February 23, 2024 Filed Mar 15, 2024 00:27 UTC Amendment |
Davis John EChief Commercial Officer
|
GrantCommon Stock | 5,386 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000146 · wk-form4a_1710462424.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,279 F1 · shares: Represents performance stock units granted on Feb. 22, 2023. One hundred percent (100%) were issued on Feb. 23, 2024. Read SEC document |
| February 23, 2024 Filed Mar 15, 2024 00:14 UTC Amendment |
Mackin James PPresident & CEO
|
GrantCommon Stock | 58,648 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000134 · wk-form4a_1710461680.xml · nonDerivative · entry 3 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 709,221 F4 · shares: Represents performance stock units granted on Feb. 22, 2023. Fifty percent (50%) were issued on Feb. 23, 2024. The remaining shares earned in connection with the Feb. 2023 grant will be eligible to vest and be issued as follows: 25% on 02/22/2025; and 25% on 02/22/2026, assuming employment on the relevant vesting date. F3 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4. Read SEC document |
| February 23, 2024 Filed Mar 15, 2024 00:14 UTC Amendment |
Mackin James PPresident & CEO
|
GrantCommon Stock | 40,404 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000134 · wk-form4a_1710461680.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 668,441 F1 · shares: Represents performance stock units granted on Feb. 22, 2023. One hundred percent (100%) were issued on Feb. 23, 2024. Read SEC document |
| February 23, 2024 Filed Mar 15, 2024 00:04 UTC Amendment |
Getz Matthew AVP, Human Resources
|
GrantCommon Stock | 7,412 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000126 · wk-form4a_1710461069.xml · nonDerivative · entry 3 Getz Matthew A · CIK 0001784253 · VP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,552 F4 · shares: Represents performance stock units granted on Feb. 22, 2023. Fifty percent (50%) were issued on Feb. 23, 2024. The remaining shares earned in connection with the Feb. 2023 grant will be eligible to vest and be issued as follows: 25% on 02/22/2025; and 25% on 02/22/2026, assuming employment on the relevant vesting date. F3 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4. Read SEC document |
| February 23, 2024 Filed Mar 15, 2024 00:04 UTC Amendment |
Getz Matthew AVP, Human Resources
|
GrantCommon Stock | 3,366 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000126 · wk-form4a_1710461069.xml · nonDerivative · entry 1 Getz Matthew A · CIK 0001784253 · VP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,308 F1 · shares: Represents performance stock units granted on Feb. 22, 2023. One hundred percent (100%) were issued on Feb. 23, 2024. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 22:37 UTC |
Holloway Jean FSVP, General Counsel
|
SaleCommon Stock | 1,192 | $18.87 | $22,487.08 |
DisclosureSEC source: 0000784199-24-000028 · wk-form4_1708641463.xml · nonDerivative · entry 3 Holloway Jean F · CIK 0001540065 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,858 F1 · shares: These shares were sold upon the vesting of Restricted Stock awards to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 22:37 UTC |
Holloway Jean FSVP, General Counsel
|
SaleCommon Stock | 464 | $18.87 | $8,753.36 |
DisclosureSEC source: 0000784199-24-000028 · wk-form4_1708641463.xml · nonDerivative · entry 2 Holloway Jean F · CIK 0001540065 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,050 F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 22:37 UTC |
Holloway Jean FSVP, General Counsel
|
SaleCommon Stock | 1,871 | $18.87 | $35,296.42 |
DisclosureSEC source: 0000784199-24-000028 · wk-form4_1708641463.xml · nonDerivative · entry 1 Holloway Jean F · CIK 0001540065 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,514 F1 · shares: These shares were sold upon the vesting of Restricted Stock awards to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 22:35 UTC |
Horton AmyVP, Chief Accounting Officer
|
SaleCommon Stock | 366 | $18.87 | $6,904.59 |
DisclosureSEC source: 0000784199-24-000026 · wk-form4_1708641295.xml · nonDerivative · entry 2 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,345 F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 22:35 UTC |
Horton AmyVP, Chief Accounting Officer
|
SaleCommon Stock | 1,329 | $18.87 | $25,071.59 |
DisclosureSEC source: 0000784199-24-000026 · wk-form4_1708641295.xml · nonDerivative · entry 1 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,711 F1 · shares: These shares were sold upon the vesting of Restricted Stock awards to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 22:32 UTC |
Davis John EChief Commercial Officer
|
SaleCommon Stock | 496 | $18.87 | $9,357.04 |
DisclosureSEC source: 0000784199-24-000024 · wk-form4_1708641140.xml · nonDerivative · entry 2 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,177 F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 22:32 UTC |
Davis John EChief Commercial Officer
|
SaleCommon Stock | 2,060 | $18.87 | $38,861.90 |
DisclosureSEC source: 0000784199-24-000024 · wk-form4_1708641140.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,673 F1 · shares: These shares were sold upon the vesting of Restricted Stock awards to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 22:29 UTC |
Maney Rochelle L.VP, Quality
|
SaleCommon Stock | 407 | $18.87 | $7,678.06 |
DisclosureSEC source: 0000784199-24-000022 · wk-form4_1708640975.xml · nonDerivative · entry 1 Maney Rochelle L. · CIK 0001850597 · VP, Quality 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,123 F1 · shares: These shares were sold upon the vesting of Restricted Stock to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 22:26 UTC |
Getz Matthew AVP, Human Resources
|
SaleCommon Stock | 366 | $18.87 | $6,904.59 |
DisclosureSEC source: 0000784199-24-000020 · wk-form4_1708640771.xml · nonDerivative · entry 2 Getz Matthew A · CIK 0001784253 · VP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,692 F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 22:26 UTC |
Getz Matthew AVP, Human Resources
|
SaleCommon Stock | 1,329 | $18.87 | $25,071.59 |
DisclosureSEC source: 0000784199-24-000020 · wk-form4_1708640771.xml · nonDerivative · entry 1 Getz Matthew A · CIK 0001784253 · VP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,058 F1 · shares: These shares were sold upon the vesting of Restricted Stock awards to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 22:22 UTC |
Tyrs FlorianVP, Global Operations
|
SaleCommon Stock | 249 | $18.87 | $4,697.39 |
DisclosureSEC source: 0000784199-24-000018 · wk-form4_1708640525.xml · nonDerivative · entry 1 Tyrs Florian · CIK 0001983377 · VP, Global Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,253 F1 · shares: These shares were sold upon the vesting of Restricted Stock to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 22:08 UTC |
Mackin James PPresident & CEO
|
Exercise / conversionStock Option(Right to Buy) · Derivative | 59,225 | $0.00 Strike: $16.30 | $0.00 |
DisclosureSEC source: 0000784199-24-000016 · wk-form4_1708639663.xml · derivative · entry 5 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 59,225 shares Expires 2024-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 02/21/2018. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 22:08 UTC |
Mackin James PPresident & CEO
|
SaleCommon Stock | 2,756 | $18.87 | $51,991.94 |
DisclosureSEC source: 0000784199-24-000016 · wk-form4_1708639663.xml · nonDerivative · entry 4 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 539,036 F4 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 22:08 UTC |
Mackin James PPresident & CEO
|
SaleCommon Stock | 10,088 | $18.87 | $190,310.12 |
DisclosureSEC source: 0000784199-24-000016 · wk-form4_1708639663.xml · nonDerivative · entry 3 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 541,792 F3 · shares: These shares were sold upon the vesting of Restricted Stock awards to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 22:08 UTC |
Mackin James PPresident & CEO
|
SaleCommon Stock | 59,225 | $18.85 | $1,116,515.62 |
DisclosureSEC source: 0000784199-24-000016 · wk-form4_1708639663.xml · nonDerivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 551,880 F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 11, 2023. F2 · price: Reflects weighted average price. Range of prices were between $18.05 to $19.295. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 22:08 UTC |
Mackin James PPresident & CEO
|
Exercise / conversionCommon Stock | 59,225 | $16.30 | $965,367.50 |
DisclosureSEC source: 0000784199-24-000016 · wk-form4_1708639663.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 611,105 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 11, 2023. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:25 UTC |
Holloway Jean FSVP, General Counsel
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 21,229 | $16.30 Strike: $16.30 | $346,032.70 |
DisclosureSEC source: 0000784199-24-000004 · wk-form4_1704403509.xml · derivative · entry 3 Holloway Jean F · CIK 0001540065 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,229 shares Expires 2024-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 02/21/2018. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:25 UTC |
Holloway Jean FSVP, General Counsel
|
SaleCommon Stock | 21,229 | $18.00 | $382,122.00 |
DisclosureSEC source: 0000784199-24-000004 · wk-form4_1704403509.xml · nonDerivative · entry 2 Holloway Jean F · CIK 0001540065 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 133,520 F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on February 22, 2023. F2 · price: Reflects the price the shares were sold. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:25 UTC |
Holloway Jean FSVP, General Counsel
|
Exercise / conversionCommon Stock | 21,229 | $16.30 | $346,032.70 |
DisclosureSEC source: 0000784199-24-000004 · wk-form4_1704403509.xml · nonDerivative · entry 1 Holloway Jean F · CIK 0001540065 · SVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 154,749 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on February 22, 2023. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:22 UTC |
Davis John ESenior VP, Global Sales
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 13,562 | $16.30 Strike: $16.30 | $221,060.60 |
DisclosureSEC source: 0000784199-24-000002 · wk-form4_1704403334.xml · derivative · entry 3 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,562 shares Expires 2024-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 02/21/2018. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:22 UTC |
Davis John ESenior VP, Global Sales
|
SaleCommon Stock | 13,562 | $18.00 | $244,116.00 |
DisclosureSEC source: 0000784199-24-000002 · wk-form4_1704403334.xml · nonDerivative · entry 2 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 128,733 F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on February 23, 2023. F2 · price: Reflects the price the shares were sold. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:22 UTC |
Davis John ESenior VP, Global Sales
|
Exercise / conversionCommon Stock | 13,562 | $16.30 | $221,060.60 |
DisclosureSEC source: 0000784199-24-000002 · wk-form4_1704403334.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 142,295 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on February 23, 2023. Read SEC document |
| December 31, 2023 Filed Jan 31, 2024 01:09 UTC |
Holloway Jean FSVP, General Counsel
|
GrantCommon Stock | 472 | $14.61 | $6,896.63 |
DisclosureSEC source: 0000784199-24-000008 · wk-form5_1706663381.xml · nonDerivative · entry 2 Holloway Jean F · CIK 0001540065 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,385 F1 · price: These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3. Read SEC document |
| December 31, 2023 Filed Jan 31, 2024 01:00 UTC |
Stanton Marshall S.SVP, Clinical & MD Affair
|
GrantCommon Stock | 565 | $14.61 | $8,255.50 |
DisclosureSEC source: 0000784199-24-000006 · wk-form5_1706662850.xml · nonDerivative · entry 2 Stanton Marshall S. · CIK 0001849615 · SVP, Clinical & MD Affair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,903 F1 · price: These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 22:23 UTC |
Horton AmyVP, Chief Accounting Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 14,397 | $16.30 Strike: $16.30 | $234,671.10 |
DisclosureSEC source: 0000784199-23-000163 · wk-form4_1703024616.xml · derivative · entry 3 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,397 shares Expires 2024-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 02/21/2018. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 22:23 UTC |
Horton AmyVP, Chief Accounting Officer
|
SaleCommon Stock | 14,397 | $19.00 | $273,543.00 |
DisclosureSEC source: 0000784199-23-000163 · wk-form4_1703024616.xml · nonDerivative · entry 2 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 124,040 F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on February 22, 2023. F2 · price: Reflects the price the shares were sold. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 22:23 UTC |
Horton AmyVP, Chief Accounting Officer
|
Exercise / conversionCommon Stock | 14,397 | $16.30 | $234,671.10 |
DisclosureSEC source: 0000784199-23-000163 · wk-form4_1703024616.xml · nonDerivative · entry 1 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 138,437 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on February 22, 2023. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 14:16 UTC |
Berry Lance AExecutive VP, CFO
|
GrantStock Option (Right to Buy) · Derivative | 93,633 | $0.00 Strike: $17.83 | $0.00 |
DisclosureSEC source: 0000784199-23-000161 · wk-form4_1702044996.xml · derivative · entry 2 Berry Lance A · CIK 0001478716 · Executive VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,633 Underlying: Common Stock · 93,633 shares Expires 2030-12-06 F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 14:16 UTC |
Berry Lance AExecutive VP, CFO
|
GrantCommon Stock | 42,064 | $17.83 | $750,001.12 |
DisclosureSEC source: 0000784199-23-000161 · wk-form4_1702044996.xml · nonDerivative · entry 1 Berry Lance A · CIK 0001478716 · Executive VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,064 F1 · balance_after: Represents shares of restricted stock that vest on the third anniversary of the grant date, pursuant to the terms of the Equity and Cash Incentive Plan. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 14:09 UTC |
Horton AmyVP, Chief Accounting Officer
|
GrantCommon Stock | 20,191 | $17.83 | $360,005.53 |
DisclosureSEC source: 0000784199-23-000157 · wk-form4_1702044554.xml · nonDerivative · entry 1 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,040 F1 · balance_after: Represents shares of restricted stock 50% vests on the first anniversary and 50% vests on the second anniversary of the grant date, pursuant to the terms of the Equity and Cash Incentive Plan. Read SEC document |
| November 27, 2023 Filed Nov 29, 2023 14:15 UTC |
Horton AmyVP, Chief Accounting Officer
|
GiftCommon Stock | 1,750 | $17.51 | $30,642.50 |
DisclosureSEC source: 0000784199-23-000152 · wk-form4_1701267350.xml · nonDerivative · entry 2 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,849 F2 · shares: 1,750 shares were gifted by the reporting person to a charity. Read SEC document |
| November 27, 2023 Filed Nov 29, 2023 14:15 UTC |
Horton AmyVP, Chief Accounting Officer
|
SaleCommon Stock | 2,101 | $17.34 | $36,431.34 |
DisclosureSEC source: 0000784199-23-000152 · wk-form4_1701267350.xml · nonDerivative · entry 1 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,599 F1 · price: Reflects the price the shares were sold. Read SEC document |
| August 08, 2023 Filed Aug 10, 2023 12:48 UTC |
Tyrs FlorianVP, Global Operations
|
GrantStock Option (Right to Buy) · Derivative | 4,699 | $0.00 Strike: $16.79 | $0.00 |
DisclosureSEC source: 0000784199-23-000141 · wk-form4_1691671730.xml · derivative · entry 3 Tyrs Florian · CIK 0001983377 · VP, Global Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,699 Underlying: Common Stock · 4,699 shares Expires 2030-08-08 F2 · derivative.expiration_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date Read SEC document |
| August 08, 2023 Filed Aug 10, 2023 12:48 UTC |
Tyrs FlorianVP, Global Operations
|
GrantCommon Stock | 2,107 | $16.79 | $35,376.53 |
DisclosureSEC source: 0000784199-23-000141 · wk-form4_1691671730.xml · nonDerivative · entry 1 Tyrs Florian · CIK 0001983377 · VP, Global Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,502 F1 · balance_after: Represents shares of restricted stock that vest on the third anniversary of the grant date, pursuant to the terms of the Equity and Cash Incentive Plan. Read SEC document |
| June 30, 2023 Filed Jan 31, 2024 01:12 UTC |
Davis John ESenior VP, Global Sales
|
GrantCommon Stock | 2,000 | $10.30 | $20,604.00 |
DisclosureSEC source: 0000784199-24-000010 · wk-form5_1706663520.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,733 F1 · price: These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3. Read SEC document |
| June 30, 2023 Filed Jan 31, 2024 01:09 UTC |
Holloway Jean FSVP, General Counsel
|
GrantCommon Stock | 1,393 | $10.30 | $14,350.69 |
DisclosureSEC source: 0000784199-24-000008 · wk-form5_1706663381.xml · nonDerivative · entry 1 Holloway Jean F · CIK 0001540065 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,913 F1 · price: These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.